==== Front Vet Med (Auckl)Vet Med (Auckl)Veterinary Medicine: Research and ReportsVeterinary Medicine : Research and Reports2230-2034Dove Medical Press 10.2147/VMRR.S63536vmrr-6-193ReviewEmerging insights into the genetic basis of canine hip dysplasia Ginja Mário 1Gaspar Ana Rita 1Ginja Catarina 23 1 Department of Veterinary Sciences-CITAB, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal, mginja@utad.pt 2 Ce3C – Centro de Ecologia, Evolução e Alterações Ambientais, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal 3 CIBIO-InBIO – Centro de Investigação em Biodiversidade e Recursos Genéticos, Universidade do Porto, Vairão, PortugalCorrespondence: Mário Ginja, Department of Veterinary Science-CITAB, University of Trás-os-Montes and Alto Douro, Quinta de Prados, 5000-801 Vila Real, Portugal, Tel +351 259 350 666, Fax +351 259 350 480, Email mginja@utad.pt2015 20 5 2015 6 193 202 © 2015 Ginja et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License2015The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.Canine hip dysplasia (CHD) is the most common inherited polygenic orthopedic trait in dogs with the phenotype influenced also by environmental factors. This trait was described in the dog in 1935 and leads to a debilitating secondary hip osteoarthritis. The diagnosis is confirmed radiographically by evaluating signs of degenerative joint disease, incongruence, and/or passive hip joint laxity. There is no ideal medical or surgical treatment so prevention based on controlled breeding is the optimal approach. The definitive CHD diagnosis based on radiographic examination involves the exposure to ionizing radiation under general anesthesia or heavy sedation but the image does not reveal the underlying genetic quality of the dog. Phenotypic expression of CHD is modified by environmental factors and dogs with a normal phenotype can be carriers of some mutations and transmit these genes to their offspring. Programs based on selection of dogs with better individual phenotypes for breeding are effective when strictly applied but remain inferior to the selection of dogs based on estimation of breeding values. Molecular studies for dissecting the genetic basis of CHD are ongoing, but progress has been slow. In the future, the recommended method to improve hip quality in controlled breeding schemes, which will allow higher selection pressure, would be based on the estimation of the genomic breeding value. Since 2012, a commercial DNA test has been available for Labrador Retrievers using a blood sample and provides a probability for development of CHD but we await evidence that this test reduces the incidence or severity of CHD. Video abstract Keywords canine hip dysplasiaphenotypebreeding stockGWASscreeningdiagnosis ==== Body Introduction Canine hip dysplasia (CHD) is the most common inherited polygenic orthopedic trait with the phenotype influenced by environmental factors.1 This trait was described in the dog in 1935, in the USA, and leads to a debilitating secondary hip osteoarthritis.2 Heritability estimates for CHD vary from 0.1 to 0.83,3,4 due to different pedigrees, methods used to calculate the heritability, and the hip phenotypes analyzed.5 CHD is more prevalent in large and giant breeds of dogs often resulting in mild or no clinical signs.1,6 However, for some dogs clinical signs can be severe and resistant to medical management needing aggressive and expensive surgical treatments.1,7 The definitive diagnosis of CHD is made if characteristic radiographic signs are evident on a standard or stressed ventrodorsal view of the pelvis, occurring along a gradual scale from nearly normal to severely affected.1 This is a crucial aspect of CHD as the radiographic diagnosis has been essential for the selection of breeding stock.1 Studies attempting to find genetic markers for CHD diagnosis are now frequent.8–11 The sequencing and annotation of the canine genome has resulted in renewed interest in research of the genetic underpinnings of canine orthopedic disorders, particularly those of a multifactorial etiology, such as CHD.12 Recently, the first commercial CHD diagnostic genetic test for Labrador Retrievers appeared,13 but, the imaging diagnosis continues to be of major importance for disease screening and treatment. Humans are also affected by hip dysplasia and both conditions have phenotypic similarities of joint subluxation and the development of osteoarthritis.14 However, the main medical approach in humans is different, being mainly based on the preventive management and with good results.1,15 Currently, molecular CHD studies are considered useful for the understanding of the genetic basis of analogous conditions in humans, mainly because the heterogeneity in human populations and the complexity of this disorder makes the genetic dissection of human hip osteoarthritis more difficult.12 The main purpose of this review is to present and discuss medical aspects of CHD for which knowledge is incomplete and have therefore merited major current research efforts. Epidemiology, physical signs, and outcomes CHD continues to be a common trait mainly in large and giant breeds, in pet and working dogs, with prevalence higher than 50% in some breeds.2 The clinical presentation of the disease is not correlated with the radiographic changes.2,6 Clinical signs of CHD are more evident in dogs younger than 1 year of age due to hip instability, or in adult dogs with chronic pain from osteoarthritis.7,16 Chronic hip alterations, such as fibrosis and thickening of the joint capsule, result in joint stability and improvement of limb function, masking the clinical signs and functional limitations in middle-aged animals.6,17 Clinical signs warrant medical and/or surgical treatment.18,19 Preventive conservative or surgical management could be indicated in puppies at risk of developing CHD,19,20 but early intervention is hampered because there are no pathognomonic clinical signs for CHD. Common clinical signs are: slight to moderate lameness; gait and running abnormalities, such as shortened stride length and bunny hopping; difficulty in rising and reluctance to climb stairs.21 Diagnosis – physical examination and imaging Information about the conformation of the hip joint can be obtained using clinical or diagnostic imaging tests.21,22 These medical tests are usually performed on sedated or anesthetized animals and are separated into two main categories: to evaluate hip joint laxity (HJL), mainly used on young animals; to detect clinical or radiographic signs of osteoarthritis, as crepitation and reduced range of motion on joint palpation or degenerative joint disease (DJD) signs on radiographs.1,21 However, it would be very helpful to develop medical CHD screening techniques for fully conscious young animals, similar to hip dysplasia screening examination of human neonates.1 The imaging diagnosis of CHD has been the main area of research of CHD in the last 50 years, for the purposes of reproductive control. Clearly, in terms of human medicine the main focus has been different, trying to refine diagnostic accuracy and preventive management.1,15 Physical examination The Ortolani test is the most common and popular physical maneuver that is used in veterinary medicine to diagnose HJL in young dogs (4–12 months of age).23,24 Other clinical tests are described, like the Barlow’s and Barden tests for puppies younger than 4 months of age but their clinical accuracy is more questionable.1,17 The Ortolani test is performed with the dog awake, sedated or anesthetized with the patient in lateral or dorsal recumbency.23 The test has two steps, first apply proximal force to the stifle joint on the non-dependent limb, with the hip at a normal weight-bearing angle, and while still applying this force, slowly abduct the joint. In hips with abnormal laxity, the dysplastic femoral head, may be displaced dorsally beyond the dorsal acetabular rim (in the first step) and then the limb abduction promotes its reduction back into the acetabulum (in the second step) which elicits a typical palpable and/or audible clunk, of variable magnitude, commonly called a positive Ortolani sign (Figure 1).1,23 Advanced stages of CHD with destruction of the acetabular rim or in dogs younger than 4 months of age with an inadequate acetabular ossification can result in false negative cases based on the Ortolani maneuver even though HJL may be present.17,24,25 The Ortolani test showed an excellent sensitivity in prediction of CHD when used in dogs younger than 1 year of age that later developed moderate or severe CHD.24 Diagnostic imaging Radiography is the reference technique for the definitive diagnosis of CHD from its first description in 1935. This imaging technique uses different radiographic views of the hip joint for genetic screening purposes or for diagnosis and treatment of dogs with clinical CHD. All these radiographic techniques should be performed under anesthesia or heavy sedation, which facilitates accurate positioning and elicitation of passive HJL.1,3,7,19 Given the complexity of the topic and the objectives of this review, we will cover particularly the radiographic studies used for genetic screening of CHD, which are used to detect HJL, the major risk factor for CHD, or signs of DJD. The radiographic information on HJL is obtained using radiographic techniques such as PennHIP,26 dorsolateral subluxation (DLS),27 Flückiger28 and half-axial position methods.22 Signs of DJD are evaluated using the standard ventrodorsal hip-extended view (SVDV).2,29,30 Radiographic estimation of HJL In this group of methods, the PennHIP was the pioneer and is the most popular. It was developed at the University of Pennsylvania in the 1980s with the main purpose of CHD breeding control.26 One of the main advantages of this procedure is its precocity, being performed with accuracy on dogs at 16 weeks of age, compared with 1 or 2 years of age for previous screening systems.26,29,30 The PennHIP method requires certified members and is performed with three hip radiographic views: hip-extended, compression, and distraction.26 The distraction view is used to measure HJL. It is performed with the dog in dorsal recumbency, with the hips at a neutral position and the PennHIP distractor between hind limbs acting as a fulcrum lateralizing the femoral heads under examiner force.26 The radiographs are sent to the PennHIP Analysis Center at University of Pennsylvania for an official report, and the dogs are placed in rank-order with the other dogs of the breed in the database. The HJL is evaluated in the distraction view calculating the distraction index (DI), which measures the relative degree of femoral head displacement from the acetabulum.3,26 The DI ranges from 0 to >1, with 0 representing a tight hip and 1 a loose hip.26 The DLS is also a passive stress radiographic or tomographic imaging technique; the HJL is measured as the DLS score.27 The hip stress is caused by weight bearing. The DLS score has a strong correlation with DI. This method was reported in dogs at 4 and 8 months of age to evaluate the chondro-osseous acetabular and femoral head structure as an indicator of functional joint stability.27,31 In the Flückiger method, the HJL is estimated with the subluxation index in a similar manner to the DI.28 The stress in hip joints is caused by the dorsocranial force exerted by the examiner, with the dog in dorsal recumbency.28 No follow-up studies were published and the research was performed in adult animals together with the SVDV to better assess the quality of the hips. The half-axial position method was used by positioning the dog and performing the hip stress similar to the PennHIP, using a trapezoidal-shaped distractor.22 The HJL measures using this method are performed mainly with the purpose of early CHD diagnosis and treatment, using the juvenile pubic symphysiodesis (JPS). Radiographic evaluation of DJD The DJD is evaluated using the SVDV, a universal radiographic view used in dogs older than 1 (Fédération Cynologique Internationale’s [FCI] system) or 2 years (Orthopaedic Foundation for Animals [OFA] system) of age.1,29 This view has been used since the 1960s.32 The dog is placed in dorsal recumbency on the X-ray table, with hind limbs extended parallel to each other with the stifles internally rotated.1,32 Many international systems are used to evaluate DJD, including the FCI,1 OFA,29 British Veterinary Association/Kennel Club (BVA/KC),30 and the Flückiger33 method with more influence in continental European countries, USA, UK and Australia, and Switzerland, respectively. As the main guideline of all of these scoring methods is based on the degree of subluxation, joint congruence and remodeling of the femoral head and acetabulum, these scoring systems may be equal (Table 1). However, these direct comparisons between grades and schemes are considered speculative, due to their subjective nature.34 These scoring systems have some particularities: FCI requires a minimum age of 12 months in medium breeds and the OFA method 24 months; FCI scrutinizers are not certified; FCI, OFA, and BVA/KC are voluntary screening schemes. The SVDV is not strongly evaluative of HJL. It is underestimated. The parallel hip-extended positioning and the internal rotation of stifles twist the hip soft tissues, tightening the tensile elements of the joint capsule and may reduce some degree of luxation.26 Other imaging techniques Ultrasonography in human neonates is the reference technique for the definitive diagnosis of developmental hip dysplasia.35 However, the use of ultrasound in puppies for the confirmation of CHD is not recommended, as the acetabulum cannot be evaluated after 8 weeks of age because femoral head ossification and acetabular chondro-osseous alterations are only evident after this age.17 Increased synovial fluid volumes in hip joints detected by magnetic resonance imaging in 8-week-old puppies were correlated with later HJL and CHD.17 Dynamic ultrasonography was used in puppies at 8–16 weeks of age, to quantify HJL.36 HJL and osseous acetabular structure can be evaluated confidently using computed tomography.27 Prevention and treatment Some preventive conservative and surgical treatments have been proposed for young dogs with clinical predisposition for CHD.7,19 The main conservative management recommendations are based on limiting food consumption and controlled weight-bearing activity to prevent obesity and develop muscular tissues.1,37 Disease-modifying osteoarthritis drugs given by injection are recommended, as they retard breakdown and may promote the synthesis of cartilage matrix and reduce pain and inflammation.20 Analgesic or anti-inflammatory medications are effective to manage pain and lameness but should only be used for the short term due to their undesirable side effects. However, the long-term effectiveness of this conservative treatment is questionable, since their ability to prevent the development and progression of osteoarthritis is at best limited.7,19 JPS is a surgical treatment used on puppies at 14–20 weeks of age and at risk of developing CHD,19,38 with greater improvements achieved when surgery is performed at 15 weeks of age.38 JPS is a minimally invasive procedure based on induction of thermal necrosis in chondrocytes of the growth plate of the pubis.19,38 The pubic growth plate undergoes premature closure resulting in an underdeveloped ventral pelvis and normal dorsal development.7 This modified pelvic growth results in an increase in acetabular coverage of the femoral head and reduction of subluxation forces.38 This technique has been recommended in puppies with slight to moderate signs of CHD but not in animals with severe signs of CHD. In the JPS, acetabular ventroversion occurs slowly and in severe cases of CHD the femoral head continues to slide laterally, the dorsal acetabular edge becomes round and femoral head stability is never obtained.19 Triple pelvic osteotomy is a reasonable surgical treatment option for CHD being used in animals between 5 and 12 months old, without radiographic signs of DJD and with minimal or clinical signs of CHD.7 However, triple pelvic osteotomy is more effective in preventing the development of DJD when used in dogs younger than 7 months of age.7 The pelvis is cut in the pubis, ischium, and ilium, rotated and the ilium fixed with a surgical plate. This surgical procedure results in ventrolateral rotation of the acetabulum and provides immediate increased femoral head stability. However, the hips of dogs with extant osteoarthritic changes or with a high HJL continue to deteriorate and have a less favorable outcome.7 When osteoarthritis is already at an advanced stage, treatment should be performed to alleviate pain and maintain joint function.18,39 Femoral head and neck excision reduces the pain produced by abnormal bone to bone hip joint contact, but it does not effectively maintain the full range of hip motion and limb function. The total hip replacement is the best treatment to preserve long-term limb functionality. Genetic and environmental factors in the pathogenesis of CHD CHD is a complex polygenic disease due to the small additive effect of many genes.4,8 Environmental factors such as sex, age, and body weight can influence the expression and severity of the disease.37 It appears that CHD is not a congenital disease, hips are normal at birth with adequate femoral head and acetabular congruence. The first 60 days of a puppy’s life is thought to be the most critical period in terms of development of the hip joint.16 In this period, the depth of the acetabular cavity and the proximal femoral head and neck conformation are susceptible to modeling according to the stress loading.15 In a normal congruent hip joint, the normal weight bearing force is transmitted between femoral head and acetabulum across the surface of the articular cartilage. The joint incongruence favors the reduction of contact between the cartilaginous surfaces, the early destruction of chondrocytes by increasing pressure and the cyclic cascade of osteoarthritis. Small synovial joint volume and low intracapsular pressure, high pelvic muscle mass, and a reduced level of the hormones that promote soft tissue relaxation maintain stability and prevent the development of CHD signs.26 The HJL is the primary risk factor, well-evaluated in a radiographic study that is associated with CHD development.40 Acetabular and proximal femoral head and neck conformation is directly associated with the magnitude of transmitted hip forces.41 So, genetic factors associated with CHD can be related to hip conformation, cartilage susceptibility to pressure forces, joint soft tissues or even to hormonal factors. Published heritabilities of CHD traits are variable and commonly range between 0.1 to 0.60.12,42 Differences of heritability estimates depend on the trait used, calculation method, selection, the population and sample used for estimation.5,42 For example, heritability reached as high as 0.83 for passive hip laxity in the Estrela Mountain dog breed from Portugal.3 The genetic improvement used in selection of traits with higher heritabilities and similar selection pressures will be bigger per generation.1 Selection of breeding stock with low hip scores – progress toward reducing incidences of hip dysplasia Because there is no ideal medical or surgical treatment, veterinarians in practice are at the forefront, and their main focus is on prevention of CHD through reproductive control.43 Selection of breeding stock has clearly been a priority intervention area of veterinary medicine. Control CHD programs based on radiographic phenotype quality of hips were used in some countries as early as the 1960s.44–46 These programs were based on radiographic screening of CHD using the SVDV and scores of hip quality based on DJD signs and hip congruence. Selection of breeding stock was based on an individual dog’s hip phenotype and subjective pedigree evaluation performed by the breeder. The results of phenotype-based genetic screening on CHD prevalence and severity are somewhat disparate in different countries and breeds. When the CHD control schemes are voluntary, as the OFA, FCI, and BVA/KC, only the better hip phenotypes are scrutinized and the studies performed using these databases are biased.2,42 Using the OFA scoring scheme and the best linear unbiased prediction method for the estimation of breeding values and its application in the selection for hip joint conformation, for Labrador Retrievers the total genetic improvement in four decades (1970–2007) corresponded to only ~17% of the total phenotypic standard deviation.12 However, radiographs of dogs with normal-appearing hips are several times more likely to be submitted for evaluation in the OFA system than radiographs of dogs that are severely dysplastic.47 For example, in a closed breeding colony of German Shepherd dogs and Labrador Retrievers, CHD prevalence over five generations of selection decreased from 55% to 24%, and from 30% to 10%, respectively.46 Selective breeding against CHD was less effective in decreasing its prevalence and severity in Sweden.44 In other countries, such as Finland, the general CHD control program was even considered ineffective in reducing the prevalence of CHD in various dog breeds.45 For the PennHIP method, there are no reports of its effectiveness in reducing the prevalence of CHD in different dog populations. Theoretically, it is a promising method since studies have shown that HJL has a higher heritability than the CHD scores based on DJD. The lack of desired success of CHD control programs that rely totally on individual phenotype has been due partly to its sensitivity to environmental factors. Animals with a normal individual radiographic phenotype can still be carriers of CHD genes, which will be transmitted to their offspring and maintained in the population.48 Estimated breeding values (EBV) are commonly used in farm animal selection for complex polygenic traits (phenotype expression is influenced by environmental factors), such as milk yield or growth rate.28,49 So, the phenotypic expressions of these traits are very similar to CHD, determined by heredity and environment. The EBV for CHD is a genetic parameter derived from the hip quality of relatives, and is thus more representative of the dog’s genetic quality,12,44 and allows monitoring of the genetic trends in dog populations,50 being recommended for CHD selection purposes.51,52 With the rapid development of high-throughput sequencing technology and emergence of high-density genome-wide single nucleotide polymorphisms (SNPs) canine arrays, associations between genetic markers in linkage disequilibrium and CHD genes have been discovered.14,42 The molecular genetic information can be applied for CHD selection purposes, particularly if the most informative SNPs are used to estimate the genomic breeding value (GBV) of an individual. Such genomic selection was successfully applied in livestock animal breeding programs and can be used for selection against prevalence of undesired traits with greater genetic improvement.10,42,43,53 In the near future, GBV might become the recommended method to improve hip quality in CHD control schemes.12,43,53 In a particular dog breed, pedigree and phenotypic data can be used to obtain EBV and combined with genomic data to derive a predictive formula for the GBV.12 Then, the genotyping of a puppy for a set of informative SNPs can be combined with radiographic information, and used to determine the susceptibility to CHD and make decisions regarding breed management. Genome-wide association studies (GWAS) and genetic analyses in the identification of susceptibility alleles The genetic etiology of CHD has been proven and accepted by the scientific community.54 The first molecular studies for CHD diagnosis were developed by Todhunter et al in the 1990s at Cornell University, who began by searching for molecular genetic markers that were linked to quantitative trait loci (QTL) responsible for different CHD phenotypes.9,55 To optimize the linkage of genes to CHD traits an outcross between breeds with high and low susceptibility to develop CHD, Labrador Retrievers and Greyhounds, respectively, was implemented. Twelve chromosomes were identified to harbor putative QTL for different CHD traits.9 QTL were also associated to the Norberg angle8 and acetabular osteophyte formation.56 Recently, more QTL were associated with other CHD traits.10,57 Pedigree and CHD phenotype analysis showed some evidence of a major QTL (contributing about 20% of variance) associated to CHD in several studies.46,58–60 However, the QTL region may contain hundreds of genes and the identification of genes remains problematic.4 The strategy that is followed by some researchers is to refine the QTL interval using SNPs and across-breed-mapping thus reducing the linkage disequilibrium interval.4 Unrelated affected animals with CHD probably share more common disease alleles than an unaffected dog population.4 The associated SNPs might be physically next to the responsible gene.14 GWAS consider the joint effect of multiple SNPs, being much more effective than individual SNP analysis, in the identification of common genetic variants for complex diseases.14 In eight different dog breeds using GWAS, four SNPs were significantly associated with CHD on CFA3, 11, and 30, and two with osteoarthritis on CFA17 and 37.14 In German Shepherd dogs, 13 SNPs were also associated with CHD on chromosome CFA14 and 37,61 CFA19, 24, 26, and 34,11 and CFA3, 9, 26, 33, and 34.62 In other recent studies on Labrador Retrievers, four SNPs were associated with CHD on chromosome CFA1 and 21,10 and 31 SNPs on CFA1, 5, 8, 15, 20, 25, and 32 positioned within or in the vicinity of 24 different genes (Table 2).63 Candidate genes involved in hypertrophic differentiation of chondrocytes and extracellular matrix integrity of basement membrane and cartilage were located in significantly associated regions on CFA1, 8, 20, and 25.63 These results confirm the complex genetic architecture of CHD, based on many genes with small individual effect, which encourages circumspection about a marker-assisted, accurate CHD diagnostic test in the near future. The immediate importance of CHD molecular diagnosis will probably be their use in genomic (many markers assessed for their combined contribution) selection. One mutation in the FBN2 gene on CFA11 chromosome was significantly associated with CHD in Labrador Retrievers and other dog breeds.64 However, other genes must be involved in CHD because the FBN2 locus only explains a small part of the genetic trait variation in CHD.64 Studies on QTL and/or SNPs associated with other phenotypes of CHD, such as the passive hip laxity, could provide additional information on the genetic basis of this condition. Passive hip laxity is the highest risk factor for CHD and is the trait associated with the highest heritability.3,40 Genetic studies regarding the developmental hip dysplasia in humans were unable to make much progress, so knowledge on the loci-linked hip dysplasia in humans is still limited.12 Despite recent developments in whole-genome analysis in humans, with the finding of a number of genetic variants associated with this condition in affected patients,65,66 understanding the genetics of hip dysplasia in humans can benefit from similar studies in the dog. Prospects for the development of commercially available DNA tests for screening and diagnosis A DNA-based test for CHD is a desirable tool for early identification of dogs susceptible or resistant to the disease. In 2012, such a test was registered by Bioiberia. Called Dysgen, it was the first commercial marker-based DNA test for susceptibility to CHD in the Labrador Retriever breed. This test analyzes blood samples using a DNA kit containing seven SNPs.13 The Dysgen diagnosis is reported as a prediction, classifying the dog into a risk group for developing CHD – minimal, low, moderate, and high. However, the performance of the Dysgen diagnosis test was not independently tested and there are no published studies reporting its success in the control for CHD at the population level. Breeding of dogs with minimal or low risk of developing CHD is recommended by the manufacturer. This is a first step in the molecular diagnosis of CHD, but until all the genes involved in the disease are detected, CHD control programs continue to require the combination of an accurate phenotype screening, EBV, and the information of available genetic tests. Particularly, if the heritability of the trait is low effectiveness of selection will benefit from combining information on major gene genotypes and EBV. Moreover, if we consider that CHD affects a rather large group of distinct dog breeds, from the Alaskan Malamute to the Portuguese Water Dog and which are raised in different environments, we require a deep understanding of the genetics underlying the incidence of this condition at the population level. Conclusion Despite phenotypic screening and breeding programs, CHD continues to be one of the most common orthopedic hereditary diseases in dogs. There is no ideal diagnosis or treatment for CHD and reproductive control schemes have been, in the last 50 years, a priority area of veterinary medicine to deal with the disease. The genetic architecture of CHD is complex, as the many associated genes have small individual effect. This fact makes the development of a marker-assisted accurate CHD diagnosis test difficult, despite intensive research worldwide. The molecular diagnosis of CHD will be based on genomic selection until all contributing and critical mutations are identified, and may have a significant impact for a better understanding of the genetic basis of similar conditions in humans. Acknowledgments C Ginja received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number PCOFUND-GA-2009-246542 and from the Fundação para a Ciência e a Tecnologia, Portugal, through a Marie Curie/Welcome II fellowship (Ref DFRH/WIIA/15/2011). The authors are grateful to R Todhunter (College of Veterinary Medicine, Cornell University) for expert critical review of the manuscript and helpful comments. Disclosure The authors declare no conflicts of interest regarding this work. Figure 1 Ortolani test performed with the dog in lateral recumbency. Notes: The hip is positioned in a neutral position with the femur parallel to the table and firm pressure is applied along the long axis of the femur (arrow), which causes subluxation of the femoral head when there is increased hip joint laxity (A). While still applying proximal force, the limb is slowly abducted (arrow), and the femoral head brought back into position within the acetabulum eliciting a typical palpable and/or audible clunk (B). Reprinted from The Veterinary Journal, 184(3), Ginja MM, Silvestre AM, Gonzalo-Orden JM, Ferreira AJ. Diagnosis, genetic control and preventive management of canine hip dysplasia: a review, 269–276. Copyright (2010), with permission from Elsevier.1 Table 1 Comparison of CHD scoring systems FCI OFA BVA/KC Australia Switzerland A Excellent 0–4 (no >3/hip) 0–2 Good 5–10 (no >6/hip) Fair 11–18 B Borderline 19–25 3–6 C Mild 26–35 7–12 D Moderate 36–50 13–18 E Severe 51–106 >18 Notes: FCI’s hip dysplasia grading in five categories using as reference the worst hip; OFA hip dysplasia grading in seven categories using as reference the worst hip; BVA/KC hip dysplasia score resulting from the sum of both hips, each hip joint is scored between 0 and 53 based on the severity of nine morphological radiographic changes resulting from laxity and degenerative joint disease, with each change scored from 0 (normal) to 6 (worst); Switzerland, the worst joint defines the score of hip dysplasia for the dog, each hip joint is scored between 0 and 30 based on the severity of six morphological radiographic changes resulting from laxity and degenerative joint disease, each change is scored from 0 (normal) to 5 (worst). Abbreviations: CHD, canine hip dysplasia; FCI, Fédération Cynologique Internationale; OFA, Orthopaedic Foundation for Animals; BVA/KC, British Veterinary Association/Kennel Club. Table 2 Summary of the SNPs and nearby candidate genes identified in six genome-wide association studies of canine hip dysplasia and other related traits in reference breeds SNP/trait CFA Position (bp) Allele (nt) Distance (Mb)/position in gene Gene(s) Reference/breed BICF2S2459425/CHD 3 74720873 G 0.900 EVC, EVC2 Zhou et al14/eight different breeds BICF2P550340/CHD 11 32935770 T 0.220 PTPRD BICF2S23432143/CHD 11 57517597 G 0.394 COL15A1 BICF2P799261/CHD 30 13883057 C 0.109 MAGP1 BICF2G63020552/OA 17 48092910 T 0.060 REG3A BICF2P1242205/OA 37 17299306 C 0.070 PARD3B BICF2P1089246/CHD 14 23811133 C 0.183 PON2 Pfahler and Distl61/BMD BICF2P1282232/CHD 14 59537633 T NA NA BICF2S23052396/CHD 37 25095511 A 0.361 FN1 G:37139132G>A/CHD 3 77186 A NA PGM2 Fels et al62/German Shepherd dog BICF2S22937555/CHD 9 54312 G NA NA BICF2P844355/CHD 26 32016 A NA NA G:973418T>G/CHD 33 3975 T NA EPHA3, EPHA6, PCNP G:4052195T>C/CHD 33 7022 T NA G:7967386T>C/CHD 33 10983 C NA G:414871G[A/CHD 34 3422 A NA TRIO, SEMA5A, SLC6A3, FGF12 G:4846215A>G/CHD 34 7851 G NA G:11239992A>G/CHD 34 14246 A NA G:11547417T>G/CHD 34 27034 G NA TIGRP2P265674/CHD 19 35.533 C NA NA Fels and Distl11/German BICF2S2367279/CHD 24 28.944 G NA SRC Shepherd dog BICF2P281364/CHD 26 17.181 G NA KSR2 BICF2P1086886/CHD 34 4.239 T 0.7 TRIO BICF2P355865/CHD 34 39.346 A NA NA BICF2P219706/left CrAE 1 100106009 G Genes in region 99–110 Mb SHC3, SEMA4D, OMD, OGN, PHF2, BARX1, ZNF677 Sánchez-Molano et al10/Labrador Retriever BICF2S2443186/left CrAE 1 100138261 A BICF2P1285984/left CrAE 1 107719908 G BICF2P429643/right Norberg angle 21 43337454 G 1.5 OTOG, SOX6, SAA, MYOD1, SERGEF NA/CHD 1 70938018 T/A Intron LAMA2 Lavrijsen et al63/Labrador Retriever NA/CHD 1 70997779 A/T Exon, synonymous LAMA2 NA/CHD 5 59194609 G/– 3′-UTR KLHL17 NA/CHD 5 62929475 C/T 5′-UTR NPHP4 NA/CHD 8 29247021 C/T 3′-UTR LRR1 NA/CHD 8 31496895 C/T Downstream PTGDR NA/CHD 8 31496910 C/T NA/CHD 20 45260332 A/G Exon, non-synonymous LTF NA/CHD 20 46671813 C/G Intron PBX4 NA/CHD 20 46706734 A/G 3′-UTR CILP2 NA/CHD 20 47636184 G/A 3′-UTR GDF15 NA/CHD 20 47714388 G/A 5′-UTR LSM4 NA/CHD 20 48071192 G/A Upstream INSL3 NA/CHD 20 48243399 G/– 3′-UTR NA NA/CHD 20 48804130 G/A Exon, synonymous NWD1 NA/CHD 20 49019261 T/C Intron CHERP NA/CHD 20 49318725 C/T Exon, synonymous CIB3 NA/CHD 25 47629272 C/T Upstream INPP5D NA/CHD 25 47666842 G/A Exon, synonymous INPP5D NA/CHD 25 47685188 C/T Intron INPP5D NA/CHD 25 48075297 C/G Exon, non-synonymous LOC100688622 NA/CHD 25 48076278 G/A Downstream LOC100688622 NA/CHD 25 48396330 C/T Intron SPP2 NA/CHD 25 50050076 G/A Downstream ASB18 NA/CHD 25 50228063 C/G Intron IQCA1 NA/CHD 25 51029326 G/A Intron COL6A3 NA/CHD 25 51031100 A/G Exon, synonymous COL6A3 NA/CHD 25 51040259 A/G NA/CHD 25 51046607 G/A NA/CHD 25 51736576 T/C Upstream HES6 NA/CHD 32 11265116 –/T Downstream LOC487839 Notes: Single nucleotide polymorphisms (SNPs) are categorized by traits; gene symbols follow international nomenclature guidelines; distance is shown in Mb. Abbreviations: CHD, canine hip dysplasia; OA, osteoarthritis; CrAE, cranial acetabular edge; CFA, Canis familiaris autosome; bp, position in base pair; nt, nucleotide allele; Mb, megabase; BMD, Bernese Mountain dog; NA, not applicable; UTR, untranslated region. ==== Refs References 1 Ginja MM Silvestre AM Gonzalo-Orden JM Ferreira AJ Diagnosis, genetic control and preventive management of canine hip dysplasia: a review Vet J 2010 184 3 269 276 19428274 2 Ginja MM Silvestre AM Colaço J Hip Dysplasia in Estrela mountain dogs – prevalence and genetic trends 1991–2005 Vet J 2009 182 2 275 282 18722145 3 Ginja MM Silvestre AM Ferreira AJ Passive hip laxity in Estrela mountain dog – distraction index, heritability and breeding values Acta Vet Hung 2008 56 3 303 312 18828482 4 Zhu L Zhang Z Friedenberg S The long (and winding) road to gene discovery for canine hip dysplasia Vet J 2009 181 2 97 110 19297220 5 Silvestre AM Ginja MM Ferreira AJ Colaço J Comparison of estimates of hip dysplasia genetic parameters in Estrela Mountain Dog using linear and threshold models J Anim Sci 2007 85 8 1880 1884 17468417 6 Barr AR Denny HR Gibbs C Clinical hip dysplasia in growing dogs: the long-term results of conservative management J Small Anim Pract 1987 28 4 243 252 7 Manley PA Adams WM Danielson KC Dueland RT Linn KA Long-term outcome of juvenile pubic symphysiodesis and triple pelvic osteotomy in dogs with hip dysplasia J Am Vet Med Assoc 2007 230 2 206 210 17223752 8 Chase K Lawler DF Adler FR Ostrander EA Lark KG Bilaterally asymmetric effects of quantitative trait loci (QTLs): QTLs that affect laxity in the right versus left coxofemoral (hip) joints of the dog (Canis familiaris ) Am J Med Genet A 2004 124A 3 239 247 14708095 9 Todhunter RJ Mateescu R Lust G Quantitative trait loci for hip dysplasia in a cross-breed canine pedigree Mamm Genome 2005 16 9 720 730 16245029 10 Sánchez-Molano E Woolliams JA Pong-Wong R Quantitative trait loci mapping for canine hip dysplasia and its related traits in UK Labrador Retrievers BMC Genomics 2014 15 833 25270232 11 Fels L Distl O Identification and validation of quantitative trait loci (QTL) for canine hip dysplasia (CHD) in German Shepherd Dogs PLoS One 2014 9 5 e96618 24802516 12 Breur GJ Lambrechts NE Todhunter RJ 2012 The Genetics of Canine Orthopaedic Traits Ostrander EA Ruvinsky A The Genetics of the dog New York CABI 2012 136 160 13 Plant and Animal Genome XXI [homepage on the Internet] Sanchez A Segarra S Blume V DNA Test to Evaluate Genetic Predisposition of Labrador Retrievers to Developing Canine Hip Dysplasia: Applications. P0630 Proceedings of the XXI Plant and Animal Genome Conference 2013 Available from: https://pag.confex.com/pag/xxi/webprogram/Paper6682.html Accessed December 4, 2014 14 Zhou Z Sheng X Zhang Z Differential genetic regulation of canine hip dysplasia and osteoarthritis PLoS One 2010 5 10 e13219 20949002 15 Wenger DR Bomar JD Human hip dysplasia: evolution of current treatment concepts J Orthop Sci 2003 8 2 264 271 12665970 16 Riser WH The dog as a model for the study of hip dysplasia: growth, form, and development of normal and dysplastic hip joint Vet Pathol 1975 12 4 244 334 17 Ginja MM Ferreira AJ Jesus SS Comparison of clinical, radiographic, computed tomographic and magnetic resonance imaging methods for early prediction of canine hip dysplasia Vet Radiol Ultrasound 2009 50 2 135 143 19400458 18 Farrell M Clements DN Mellor D Retrospective evaluation of the long-term outcome of non-surgical management of 74 dogs with clinical hip dysplasia Vet Rec 2007 160 15 506 511 17435096 19 Vezzoni A Dravelli G Vezzoni L Comparison of conservative management and juvenile pubic symphysiodesis in the early treatment of canine hip dysplasia Vet Comp Orthop Traumatol 2008 3 21 267 279 20 Lust G Williams AJ Burton-Wurster N Beck KA Rubin G Effects of intramuscular administration of glycosaminoglycan polysulfates on signs of incipient hip dysplasia in growing pups Am J Vet Res 1992 53 10 1836 1843 1456530 21 Fry TR Clark DM Canine hip dysplasia: clinical signs and physical diagnosis Vet Clin North Am Small Anim Pract 1992 3 22 551 558 22 Vezzoni A Dravelli G Corbari A The early diagnosis of canine hip dysplasia EJCAP 2005 15 2 173 184 23 Chalman JA Butler HC Coxofemoral joint laxity and the Ortolani sign J Am Anim Hosp Assoc 1985 6 21 671 676 24 Ginja MM Gonzalo-Orden JM Melo-Pinto P Early hip laxity examination in predicting moderate and severe hip dysplasia in Estrela mountain dog J Small Anim Pract 2008 49 12 641 646 18684138 25 Puerto DA Smith GK Gregor TP Relationship between results of the Ortolani method of hip joint palpation and distraction index, Norberg angle, and hip score in dogs J Am Vet Med Assoc 1999 214 4 497 501 10029850 26 Smith GK Biery DN Gregor TP New concepts of coxofemoral joint stability and the development of a clinical stress-radiographic method for quantitating hip joint laxity in the dog J Am Vet Med Assoc 1990 196 1 59 70 2295555 27 Farese JP Todhunter RJ Lust G Williams AJ Dykes NL Dorsolateral subluxation of hip joints in dogs measured in a weight-bearing position with radiography and computed tomography Vet Surg 1998 27 5 393 405 9749508 28 Flückiger MA Friedrich GA Binder H A radiographic stress technique for evaluation of coxofemoral joint laxity in dogs Vet Surg 1999 28 1 1 9 10025634 29 Corley EA Role of the Orthopedic Foundation for Animals in the control of canine hip dysplasia Vet Clin North Am Small Anim Pract 1992 22 3 579 593 1604774 30 Gibbs C The BVA/KC scoring scheme for control of hip dysplasia, interpretation of criteria Vet Rec 1997 141 11 275 284 9316245 31 Farese JP Lust G Williams AJ Dykes NL Todhunter RJ Comparison of measurements of dorsolateral subluxation of the femoral head and maximal passive laxity for evaluation of the coxofemoral joint in dogs Am J Vet Res 1999 60 12 1571 1576 10622171 32 Whittington K Banks WC Carlson WD Report of panel on canine hip dysplasia J Am Vet Med Assoc 1961 139 791 806 33 Flückiger M The standardised analysis of radiographs for hip dysplasia in dogs. Objectifying a subjective process EJCAP 1994 2 39 44 34 Soo M Worth A Canine hip dysplasia: phenotypic scoring and the role of estimated breeding value analysis N Z Vet J 2015 63 2 69 78 25072401 35 Gerscovich EO A radiologist’s guide to the imaging in the diagnosis and treatment of developmental dysplasia of the hip. I. General considerations, physical examination as applied to real-time sonography and radiography Skeletal Radiol 1997 26 7 386 397 9259095 36 O’Brien RT Dueland RT Adams WC Meinen J Dynamic ultrasonographic measurement of passive coxofemoral joint laxity in puppies J Am Anim Hosp Assoc 1997 33 3 275 281 9138240 37 Kealy RD Lawler DF Ballam JM Evaluation of the effect of limited food consumption on radiographic evidence of osteoarthritis in dogs J Am Vet Med Assoc 2000 217 11 1678 1680 11110459 38 Patricelli AJ Dueland RT Adams WM Juvenile pubic symphysiodesis in dysplastic puppies at 15 and 20 weeks of age Vet Surg 2002 31 5 435 444 12209414 39 Johnson AL Smith SW Pijanowski GJ Hungerford LL Triple pelvic osteotomy: effect on limb function and progression of degenerative joint disease J Am Anim Hosp Assoc 1998 34 3 260 264 9590455 40 Smith GK Popovitch CA Gregor TP Shofer FS Evaluation of risk factors for degenerative joint disease associated with hip dysplasia in dogs J Am Vet Med Assoc 1995 206 5 642 647 7744684 41 Weigel JP Wasserman JF Biomechanics of the normal and abnormal hip joint Vet Clin North Am Small Anim Pract 1992 22 3 513 528 1604769 42 Hou Y Wang Y Lu X Monitoring Hip and Elbow Dysplasia achieved modest genetic improvement of 74 dog breeds over 40 years in USA PLoS One 2013 8 10 e76390 24124555 43 Sánchez-Molano E Woolliams JA Blott SC Wiener P Assessing the impact of genomic selection against hip dysplasia in the Labrador Retriever dog J Anim Breed Genet 2014 131 2 134 145 24134497 44 Swenson L Audell L Hedhammar A Prevalence and inheritance of and selection for hip dysplasia in seven breeds of dogs in Sweden and benefit: cost analysis of a screening and control program J Am Vet Med Assoc 1997 210 2 207 214 9018354 45 Leppänen M Mäki K Juga J Saloniemi H Factors affecting hip dysplasia in German shepherd dogs in Finland: efficacy of the current improvement programme J Small Anim Pract 2000 41 1 19 23 10713978 46 Leighton EA Genetics of canine hip dysplasia J Am Vet Med Assoc 1997 210 10 1474 1479 9154200 47 Paster ER LaFond E Biery DN Estimates of prevalence of hip dysplasia in Golden Retrievers and Rottweilers and the influence of bias on published prevalence figures J Am Vet Med Assoc 2005 226 3 387 392 15702688 48 Mäki K Liinamo AE Ojala M Estimates of genetic parameters for hip and elbow dysplasia in Finnish Rottweilers J Anim Sci 2000 78 5 1141 1148 10834565 49 Hou Y Wang Y Lust G Retrospective analysis for genetic improvement of hip joints of cohort Labrador Retrievers in the United States: 1970–2007 PLoS One 2010 5 2 e9410 20195372 50 Wilson B Nicholas FW Thomson PC Selection against canine hip dysplasia: success or failure? Vet J 2011 189 2 160 168 21727013 51 Wilson BJ Nicholas FW James JW Genetic correlations among canine hip dysplasia radiographic traits in a cohort of Australian German Shepherd Dogs, and implications for the design of a more effective genetic control program PLoS One 2013 8 11 e78929 24244386 52 Malm S Sørensen AC Fikse WF Strandberg E Efficient selection against categorically scored hip dysplasia in dogs is possible using best linear unbiased prediction and optimum contribution selection: a simulation study J Anim Breed Genet 2013 130 2 154 164 23496016 53 Guo G Zhou Z Wang Y Canine hip dysplasia is predictable by genotyping Osteoarthritis Cartilage 2011 19 4 420 429 21215318 54 Leighton EA Linn JM Willham RL Castleberry MW A genetic study of canine hip dysplasia Am J Vet Res 1977 38 2 241 244 842921 55 Todhunter RJ Acland GM Olivier M An outcrossed canine pedigree for linkage analysis of hip dysplasia J Hered 1999 90 1 83 92 9987910 56 Chase K Lawler DF Carrier DR Lark KG Genetic regulation of osteoarthritis: A QTL regulating cranial and caudal acetabular osteophyte formation in the hip joint of the dog (Canis familiaris ) Am J Med Genet A 2005 135 3 334 335 15887284 57 Marschall Y Distl O Mapping quantitative trait loci for canine hip dysplasia in German Shepherd dogs Mamm Genome 2007 18 12 861 870 18027024 58 Todhunter RJ Bliss SP Casella G Genetic structure of susceptibility traits for hip dysplasia and microsatellite informativeness of an outcrossed canine pedigree J Hered 2003 94 1 39 48 12692161 59 Janutta V Hamann H Distl O Complex segregation analysis of canine hip dysplasia in German shepherd dogs J Hered 2006 97 1 13 20 16267165 60 Mäki K Janss LL Groen AF Liinamo AE Ojala M An indication of major genes affecting hip and elbow dysplasia in four Finnish dog populations Heredity (Edinb) 2004 92 5 402 408 14997179 61 Pfahler S Distl O Identification of quantitative trait loci (QTL) for canine hip dysplasia and canine elbow dysplasia in Bernese mountain dogs PLoS One 2012 7 11 e49782 23189162 62 Fels L Marschall Y Philipp U Distl O Multiple loci associated with canine hip dysplasia (CHD) in German shepherd dogs Mamm Genome 2014 25 5–6 262 269 24691653 63 Lavrijsen IC Leegwater PA Martin AJ Genome wide analysis indicates genes for basement membrane and cartilage matrix proteins as candidates for hip dysplasia in Labrador Retrievers PLoS One 2014 30 9 (1):e87735. 64 Friedenberg SG Zhu L Zhang Z Evaluation of a fibrillin 2 gene haplotype associated with hip dysplasia and incipient osteoarthritis in dogs Am J Vet Res 2011 72 4 530 540 21453155 65 Feldman G Dalsey C Fertala K The Otto Aufranc Award: Identification of a 4 Mb region on chromosome 17q21 linked to developmental dysplasia of the hip in one 18-member, multigeneration family Clin Orthop Relat Res 2010 468 2 337 344 19756907 66 Feldman GJ Parvizi J Sawan H Erickson JA Peters CL Linkage mapping and whole exome sequencing identify a shared variant in CX3CR1 in a large multi-generation family J Arthroplasty 2014 29 9 Suppl 238 241 24998320